Article PDF
Avoid common mistakes on your manuscript.
References
Jacob AG, Driscoll DJ, Shaughnessv WJ, Stanson AW, Clay RP, Gloviczki P: Klippel-Trenaunay syndrome: Spectrum and management. Mayo Clini Proc. 1998;73:28–36.
Luks VL, Kamitaki N, Vivero MP, Uller W, Rab R, Bovée JV. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015;166:1048–54.
Kulungowski AM, Fox VL, Burrows PE, Alomari AI, Fishman SJ. Portomesenteric venous thrombosis associated with rectal venous malformations. J Pediatr Surg. 2010;45:1221–7.
Hammer J, Seront E, Duez S, Dupont S, Van Damme A, Schmitz S, et al. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: A monocentric prospective phase II study. Orphanet J Rare Dis. 2018;13:191.
di Blasio L, Puliafito A, Gagliardi PA, Comunanza V, Somale D, Chiaverina G. PI3K/mTOR inhibition pro motes the regression of experimental vascular malformations driven by PIK3CA-activating mutations. Cell Death Dis. 2018;9:45.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sait, H., Sahi, P.K. & Kapoor, S. Portal Hypertension in a Case of Klippel Trenaunay Syndrome. Indian Pediatr 57, 754–755 (2020). https://doi.org/10.1007/s13312-020-1925-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-020-1925-4